Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,687 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 634
Recruiting: 364
Ph III recruiting: 20
Growth YoY: −14.6%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 701–707 of 707 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00002137	A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4	completed	Phase 1	—	Daiichi PharmaceuticalsINDUSTRY	1	Jun 24, 2005	clinicaltrials
NCT00002138	A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.	completed	Phase 1	—	Daiichi PharmaceuticalsINDUSTRY	1	Jun 24, 2005	clinicaltrials